Upcoming Dividend • May 15
Upcoming dividend of HK$0.12 per share Eligible shareholders must have bought the stock before 22 May 2026. Payment date: 09 June 2026. The company is not currently making a profit and its cash payout ratio is 91%. Trailing yield: 16%. Within top quartile of Hong Kong dividend payers (6.7%). Higher than average of industry peers (2.7%). Declared Dividend • Mar 23
Final dividend of HK$0.12 announced Shareholders will receive a dividend of HK$0.12. Ex-date: 22nd May 2026 Payment date: 9th June 2026 Dividend yield will be 13%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. Reported Earnings • Mar 21
Full year 2025 earnings released: HK$0.036 loss per share (vs HK$0.022 loss in FY 2024) Full year 2025 results: HK$0.036 loss per share (further deteriorated from HK$0.022 loss in FY 2024). Revenue: HK$1.35b (down 13% from FY 2024). Net loss: HK$22.6m (loss widened 65% from FY 2024). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Announcement • Mar 20
Lung Kee Group Holdings Limited, Annual General Meeting, May 18, 2026 Lung Kee Group Holdings Limited, Annual General Meeting, May 18, 2026. New Risk • Mar 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 58% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Dividend is not well covered by earnings (dividend per share is over 13x earnings per share). Announcement • Mar 05
Lung Kee Group Holdings Limited to Report Fiscal Year 2025 Results on Mar 20, 2026 Lung Kee Group Holdings Limited announced that they will report fiscal year 2025 results on Mar 20, 2026 Board Change • Jan 31
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. 3 independent directors (6 non-independent directors). Independent Non Executive Director Lamei He was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Jan 05
Lung Kee Group Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended December 31, 2025 Lung Kee Group Holdings Limited provided unaudited earnings guidance for the year ended December 31, 2025. For the period, the company expects to record a net loss of not less than HKD 21 million against HKD 14 million paid a year ago. The increase in net loss is primarily attributable to (i) the reduction of the Group's sales revenue under the tough market. Announcement • Aug 09
Lung Kee Group Holdings Limited to Report First Half, 2025 Results on Aug 22, 2025 Lung Kee Group Holdings Limited announced that they will report first half, 2025 results on Aug 22, 2025 Announcement • Mar 06
Lung Kee Group Holdings Limited to Report Fiscal Year 2024 Results on Mar 21, 2025 Lung Kee Group Holdings Limited announced that they will report fiscal year 2024 results on Mar 21, 2025 Announcement • Jan 06
Lung Kee Group Holdings Limited Announces Earnings Guidance for Year Ended December 31, 2024 Lung Kee Group Holdings Limited announced earnings guidance for year ended December 31, 2024. For the year, the Group is expected to record a net loss of not more than HKD 15 million for the year ended 31 December 2024 as compared to the net loss of HKD 72 million recorded for the year ended 31 December 2023. The reduction in net loss is primarily attributable to (i) an increase of revenue mainly due to slight improvement of economy; and (ii) an increase of profit margin for the Group's products mainly due to slight increase of selling prices. Announcement • Jan 01
Lung Kee Group Holdings Limited Announces Board Changes The board of directors of Lung Kee Group Holdings Limited announced that Mr. Lee Joo Hai (Mr. Lee) has tendered his resignation as an independent non-executive director ("INED") of the Company with effect from 31st December, 2024. Upon his resignation, Mr. Lee ceased to be the chairman of the nomination committee of the Company (the "Nomination Committee") and a member of each of the audit committee of the Company (the "Audit committee") and the remuneration committee of the Company (the "Remuneration Committee") with effect from the same date. Mr. Lee has been an INED of the Company since 2004. He resigned from the Board for devoting more time to his family and his personal pursuits. Mr. Lee has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation that needs to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. The Board also announced that Ms. He Lamei ("Ms. He"), an INED of the Company and a member of each of the Audit Committee, the Nomination Committee and the Remuneration Committee, has been appointed as the chairman of the Nomination Committee with effect from 1 January, 2025. Announcement • Aug 23
Lung Kee Group Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2024, Payable on 24 September 2024 Lung Kee Group Holdings Limited declared interim dividend of HKD 0.05 per share for the six months ended 30 June 2024. Ex-dividend date is 06 September 2024, Record date is 11 September 2024 and Payment date is 24 September 2024. Announcement • Aug 09
Lung Kee Group Holdings Limited to Report First Half, 2024 Results on Aug 23, 2024 Lung Kee Group Holdings Limited announced that they will report first half, 2024 results on Aug 23, 2024 Announcement • May 29
Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2023 Lung Kee (Bermuda) Holdings Limited announced that at the AGM held on 27 May 2024, approved and declared a final dividend of HKD 5 cents for the year ended 31 December, 2023. Announcement • Mar 23
Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024 Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024. Announcement • Mar 08
Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2023 Results on Mar 22, 2024 Lung Kee (Bermuda) Holdings Limited announced that they will report fiscal year 2023 results on Mar 22, 2024 Announcement • Feb 01
Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares Reference is made to the announcements of the Lung Kee (Bermuda) Holdings Limited dated 22 September 2023, 20 October 2023 and 19 January 2024 respectively (the “Announcements”) in relation to the Proposed Delisting. Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as those defined in the Announcements. The Company announced that the Shares will be delisted from the Official List of the Main Board of the SGX-ST with effect from 9:00 a.m. (Singapore time) on the Delisting Date, i.e. 5 February 2024. Announcement • Jan 05
Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023 Lung Kee (Bermuda) Holdings Limited informed the shareholders of the Company and potential investors that based on the latest review of the unaudited management accounts and the information of the Group currently available to the Board, the Group is expected to record a net loss of not less than HKD 70 million for the year ended 31 December 2023 as compared to the net profit of HKD 16 million recorded for the year ended 31 December 2022. The anticipated turnaround of the Group's results from profit to loss is mainly due to the continuous low level of the Group's sales revenue caused by the sluggish economic environment coupled with the unavoidable reduction of selling prices under the tough business operating environment. During the year, there are various factors such as the weak consumer sentiment amidst the outbreak of the COVID-19 pandemic for more than 3 years, the weaker-than-expected global economic recovery after the full resumption of cross-border activities over the world, the continuous trade disputes between China and the United States of America, the increase of interest rates by major economies such as the United States of America to curb inflation and the geopolitical tension in various regions, all these factors adversely affect the overall economy which slowed down global production. It has continuously generated unprecedented challenges and uncertainties to the business operating environment in which the Group operates. The continuous low level of the Group's sales revenue coupled with the reduction of selling prices and the relatively fixed operation costs resulted in the turnaround of the Group's results from profit to loss for the year ended 31 December 2023. Upcoming Dividend • Sep 01
Upcoming dividend of HK$0.05 per share at 7.6% yield Eligible shareholders must have bought the stock before 08 September 2023. Payment date: 25 September 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 7.6%. Lower than top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (2.6%). Reported Earnings • Aug 26
First half 2023 earnings released: HK$0.05 loss per share (vs HK$0.065 profit in 1H 2022) First half 2023 results: HK$0.05 loss per share (down from HK$0.065 profit in 1H 2022). Revenue: HK$708.9m (down 22% from 1H 2022). Net loss: HK$31.5m (down 177% from profit in 1H 2022). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Announcement • Aug 11
Lung Kee (Bermuda) Holdings Limited to Report First Half, 2023 Results on Aug 25, 2023 Lung Kee (Bermuda) Holdings Limited announced that they will report first half, 2023 results on Aug 25, 2023 Announcement • Jul 08
Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 Lung Kee (Bermuda) Holdings Limited provided earnings guidance for the six months ended 30 June 2023. The Board informed the shareholders of the Company (the "Shareholders") and potential investors that based on the latest review of the unaudited management accounts and the information of the Group currently available to the Board, the Group is expected to record a net loss of not less than HKD 30 million for the six months ended 30 June 2023 as compared to the net profit of HKD 41 million recorded for the six months ended 30 June 2022. The anticipated turnaround of the Group's results from profit to loss is mainly due to the significant decrease of the Group's sales revenue as the significant reduction of aggregate purchase orders in the market caused by the tough business operating environment. During the period, there are various factors such as the weak consumer sentiment amidst the outbreak of the COVID-19 pandemic for more than 3 years, the continuous trade disputes between China and the United States of America, the increase of interest rates by major economies such as the United States of America to curb inflation and the geopolitical tension in various regions, all these factors adversely affect the overall economy which slowed down global production and aggravated the tough business operating environment in which the Group operates. The significant reduction of aggregate purchase orders in the market coupled with the relatively fixed operation costs resulted in the significant decrease in the Group's revenue and the turnaround of the Group's results from profit to loss. Announcement • May 30
Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2022 Lung Kee (Bermuda) Holdings Limited announced that at the AGM held on 29 May, 2023 approved and declared a final dividend of HKD 0.06 per share for the year ended 31 December, 2022. Upcoming Dividend • May 26
Upcoming dividend of HK$0.06 per share at 5.9% yield Eligible shareholders must have bought the stock before 02 June 2023. Payment date: 19 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 5.9%. Lower than top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (2.7%). Reported Earnings • Mar 26
Full year 2022 earnings released: EPS: HK$0.025 (vs HK$0.36 in FY 2021) Full year 2022 results: EPS: HK$0.025 (down from HK$0.36 in FY 2021). Revenue: HK$1.60b (down 30% from FY 2021). Net income: HK$15.8m (down 93% from FY 2021). Profit margin: 1.0% (down from 10.0% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Announcement • Jan 07
Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022 Lung Kee (Bermuda) Holdings Limited provided earnings guidance for the year ended 31 December 2022. The Group is expected to record a decrease of not less than 90% of net profit for the year ended 31 December 2022 as compared to the year in 2021 (net profit for the year ended 31 December 2021: HKD 228 million). The decrease is mainly due to the decrease of the Group's sales revenue as the significant reduction of aggregate purchase orders in the market caused by the Coronavirus Diseases 2019 pandemic in China with tightened pandemic prevention measures and the unfavorable global economic factors. The overall market situation for the second half year of 2022 is worse than the first half year. The significant reduction of aggregate purchase orders in the market coupled with the increase of raw material costs and the relatively fixed operation costs resulted in the significant decrease in the Group's revenue and net profit. Buying Opportunity • Nov 24
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 9.4%. The fair value is estimated to be HK$3.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 16%. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 6 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Non Executive Director Lamei He was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Buying Opportunity • Nov 08
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be HK$3.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 16%. Upcoming Dividend • Sep 02
Upcoming dividend of HK$0.06 per share Eligible shareholders must have bought the stock before 09 September 2022. Payment date: 27 September 2022. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (8.2%). Higher than average of industry peers (3.5%). Reported Earnings • Aug 27
First half 2022 earnings released: EPS: HK$0.065 (vs HK$0.17 in 1H 2021) First half 2022 results: EPS: HK$0.065 (down from HK$0.17 in 1H 2021). Revenue: HK$910.1m (down 24% from 1H 2021). Net income: HK$41.0m (down 62% from 1H 2021). Profit margin: 4.5% (down from 9.1% in 1H 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment deteriorated over the past week After last week's 17% share price decline to HK$2.96, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 11x in the Machinery industry in Hong Kong. Total returns to shareholders of 42% over the past three years. Upcoming Dividend • May 30
Upcoming dividend of HK$0.20 per share Eligible shareholders must have bought the stock before 06 June 2022. Payment date: 21 June 2022. Payout ratio is on the higher end at 97%, and the cash payout ratio is above 100%. Trailing yield: 9.7%. Within top quartile of Hong Kong dividend payers (7.8%). Higher than average of industry peers (3.4%). Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 6 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Non Executive Director Lamei He was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Sep 03
Upcoming dividend of HK$0.15 per share Eligible shareholders must have bought the stock before 10 September 2021. Payment date: 28 September 2021. Trailing yield: 8.4%. Within top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.4%). Reported Earnings • Sep 01
First half 2021 earnings released: EPS HK$0.17 (vs HK$0.11 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: HK$1.19b (up 24% from 1H 2020). Net income: HK$108.0m (up 61% from 1H 2020). Profit margin: 9.1% (up from 7.0% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 3% per year. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment improved over the past week After last week's 17% share price gain to HK$3.76, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 16x in the Machinery industry in Hong Kong. Total returns to shareholders of 32% over the past three years. Upcoming Dividend • May 28
Upcoming dividend of HK$0.28 per share Eligible shareholders must have bought the stock before 04 June 2021. Payment date: 22 June 2021. Trailing yield: 7.6%. Within top quartile of Hong Kong dividend payers (5.9%). Higher than average of industry peers (2.1%). Reported Earnings • Apr 16
Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: HK$2.06b (down 9.4% from FY 2019). Net income: HK$181.1m (up 21% from FY 2019). Profit margin: 8.8% (up from 6.6% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 27
Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: HK$2.11b (down 7.3% from FY 2019). Net income: HK$181.1m (up 21% from FY 2019). Profit margin: 8.6% (up from 6.6% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Dec 31
New 90-day high: HK$2.61 The company is up 21% from its price of HK$2.16 on 30 September 2020. The Hong Kong market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Machinery industry, which is up 9.0% over the same period. Is New 90 Day High Low • Nov 09
New 90-day high: HK$2.50 The company is up 21% from its price of HK$2.06 on 11 August 2020. The Hong Kong market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Machinery industry, which is up 9.0% over the same period. Is New 90 Day High Low • Oct 16
New 90-day high: HK$2.32 The company is up 9.0% from its price of HK$2.13 on 17 July 2020. The Hong Kong market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Machinery industry, which is up 7.0% over the same period.